Finasteride Cost in Wyoming 2026

At a glance
- Cash-pay generic price / ~$12/month at Wyoming retail pharmacies (2026)
- Compounded finasteride (503A) / ~$45/month from licensed Wyoming-serving compounders
- Brand Propecia list price / ~$85/month (Merck manufacturer list)
- Wyoming Medicaid coverage / Not covered for AGA or BPH
- Telehealth prescribing / Legal in Wyoming
- Compounded 503A legality / Legal via licensed 503A compounding pharmacies
- Standard AGA dose / 1 mg oral tablet once daily
- Standard BPH dose / 5 mg oral tablet once daily
- FDA approval year / 1992 (BPH, Proscar); 1997 (AGA, Propecia)
- Key efficacy trial / Kaufman et al. 1998: 83% of men maintained or increased hair count at 2 years
What Does Finasteride Actually Cost in Wyoming Right Now?
Generic finasteride is one of the least expensive prescription drugs available in Wyoming. Cash-pay prices at retail pharmacies across Casper, Cheyenne, Laramie, and Gillette average roughly $12 per month for a 30-count supply of 1 mg tablets in 2026. Brand-name Propecia carries a manufacturer list price near $85 per month, though almost no cash-paying patient in Wyoming needs to pay that figure.
The $12 cash-pay benchmark reflects post-patent generic competition. Finasteride 1 mg lost brand exclusivity years ago, and multiple manufacturers now supply the market. GoodRx, RxSaver, and similar pharmacy-benefit discount cards regularly bring 30-tablet costs below $15 at major Wyoming chains including Walgreens, Walmart Pharmacy, and Smith's. A 90-day supply further reduces per-tablet cost, often landing at $30 to $36 for three months.
Finasteride 5 mg tablets (used for benign prostatic hyperplasia under the brand name Proscar) follow a similar pattern. Generic 5 mg 30-count supplies typically run $10 to $18 cash-pay in Wyoming, and many patients prescribed 5 mg for BPH use pill-cutters to split tablets, effectively halving cost per dose to roughly $5 to $9 per month. Pill-splitting is acceptable for immediate-release tablets but should be confirmed with a dispensing pharmacist before use.
The FDA approved finasteride 5 mg (Proscar) in 1992 for symptomatic BPH and finasteride 1 mg (Propecia) in 1997 for male-pattern hair loss. Full prescribing information is available via the FDA's accessdata portal. [1]
Kaufman et al. conducted the key two-year randomized controlled trial of finasteride 1 mg in men with androgenetic alopecia (N=879). At 24 months, 83% of men receiving finasteride maintained or increased hair count versus 28% in the placebo group (P<0.001). [2] That trial, published in the Journal of the American Academy of Dermatology in 1998, remains the foundational efficacy reference cited in the FDA label. [2]
Compounded Finasteride in Wyoming: Legal Status and Pricing
Compounded finasteride from a licensed 503A pharmacy is legal in Wyoming. The state's Board of Pharmacy permits patient-specific compounding under federal 503A standards, meaning a licensed pharmacist may compound finasteride in customized strengths or formulations when a valid prescription exists and a commercially available product does not meet a specific patient need.
Typical 503A compounded finasteride runs about $45 per month in 2026 for a 1 mg oral capsule or tablet. That price sits above the $12 generic retail benchmark, so compounding is not the cheapest route for patients who tolerate standard oral tablets. Compounding becomes relevant when a patient needs an alternative dose, a liquid suspension for swallowing difficulties, or a combination formulation such as finasteride plus minoxidil in a single oral capsule.
503B outsourcing facilities operate under stricter FDA oversight and may not dispense directly to patients without a prescription routed through a pharmacy. Wyoming residents using telehealth platforms often receive prescriptions filled by 503A pharmacies located in other states that ship to Wyoming under valid interstate compounding rules.
The FDA's guidance on compounding under sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act outlines which conditions permit non-standard formulations. [3] Compounded finasteride is not FDA-approved, meaning efficacy and safety data from branded or generic tablets do not automatically extend to compounded versions. Patients should verify that any compounding pharmacy holds a current Wyoming Board of Pharmacy recognition or valid NABP e-Profile.
A practical decision framework for Wyoming patients choosing between retail generic and compounded finasteride:
- Standard oral 1 mg tablet tolerated, no special dose needed: choose generic retail at $12/month.
- Swallowing difficulty or need for liquid form: consider 503A compounded suspension, approximately $40 to $50/month.
- Combination oral finasteride plus minoxidil in one capsule desired: 503A compounded combo, approximately $45 to $65/month depending on minoxidil dose.
- Topical finasteride (scalp application) to reduce systemic absorption: 503A topical, approximately $40 to $60/month; no FDA-approved topical finasteride product exists as of 2025.
Wyoming Medicaid and Finasteride Coverage
Wyoming Medicaid does not cover finasteride for androgenetic alopecia or BPH. The Wyoming Department of Health's Medicaid preferred drug list classifies AGA treatments as cosmetic and excludes them from coverage. BPH-indicated finasteride (5 mg) is also not on the state PDL as a covered benefit under the current formulary cycle.
Medicaid enrollees in Wyoming who need finasteride for BPH may request a prior authorization, but approval rates for this indication under the Wyoming program have been historically low given the availability of covered alpha-blocker alternatives such as tamsulosin. The American Urological Association 2021 guideline on BPH/lower urinary tract symptoms lists 5-alpha reductase inhibitors as appropriate for enlarged prostates (prostate volume greater than 30 mL), [4] which may support a PA argument, though coverage is not guaranteed.
Patients on Wyoming Medicaid who need AGA treatment should expect full out-of-pocket cost. At $12/month generic cash-pay, the annual cost is approximately $144, which is manageable for most budgets but worth confirming against current pharmacy pricing at point of dispensing.
The Centers for Medicare and Medicaid Services publishes state Medicaid drug utilization data that can help practitioners track formulary decisions. [5] Wyoming's Medicaid program is administered through the Wyoming Department of Health, and formulary updates occur on a rolling basis.
Insurance Coverage for Finasteride in Wyoming
Private insurance coverage for finasteride in Wyoming depends entirely on the indication documented in the prescription and the specific plan's formulary.
For BPH (5 mg), most commercial plans in Wyoming place generic finasteride on Tier 1 or Tier 2, resulting in $0 to $15 copays per 30-day fill. United Healthcare, Regence BlueCross BlueShield of Utah (which covers many Wyoming residents), and PacificSource plans operating in the Wyoming ACA marketplace generally cover generic finasteride 5 mg for a documented BPH diagnosis. A 2021 analysis of drug benefit claims found that 5-alpha reductase inhibitors carried average commercial plan copays of $5 to $10 for generic tier placement. [6]
For AGA (1 mg), commercial plans routinely deny coverage as a cosmetic indication. Patients who receive a finasteride 1 mg prescription labeled for AGA will almost always face a $0 insurance payment and pay full cash price. Some plans permit a prescriber to code for a different diagnosis, but doing so for coverage purposes when the actual diagnosis is AGA raises compliance concerns.
Medicare Part D plans available in Wyoming vary. Generic finasteride 5 mg for BPH appears on most Part D formularies at Tier 1, with copays ranging from $0 to $5 during initial coverage phase. The Medicare Plan Finder tool at cms.gov allows Wyoming residents to compare 2026 Part D plans by specific drug cost. [7]
Employer-sponsored plans in Wyoming's dominant industries (energy, agriculture, government) generally follow national insurer formularies. Employees should review their Summary of Benefits and Coverage document for drug tier placement before assuming coverage.
Telehealth Prescribing of Finasteride in Wyoming
Finasteride is a prescription-only drug in Wyoming, and telehealth prescribing is fully legal under current state law. Wyoming does not require an in-person visit before a clinician may prescribe finasteride for AGA or BPH via synchronous video or asynchronous questionnaire-based telehealth platforms.
The Wyoming Medical Practice Act allows licensees to establish a valid patient-provider relationship through telemedicine. Prescribers licensed in Wyoming (or holding a qualifying interstate compact license through the Interstate Medical Licensure Compact, of which Wyoming is a member) [8] may issue a finasteride prescription after a clinical evaluation conducted remotely.
Platforms such as HealthRX, Hims, Keeps, and Ro operate in Wyoming. These services typically charge a monthly subscription that bundles the clinical consultation fee with medication cost. Bundled prices range from $20 to $40 per month for generic 1 mg finasteride, which is higher than the $12 retail benchmark but includes clinician oversight, follow-up messaging, and prescription management. For patients in rural Wyoming counties (roughly 29 of Wyoming's 23 counties have fewer than one dermatologist per 10,000 residents), telehealth may be the only practical access point for AGA treatment.
The Federation of State Medical Boards published updated telemedicine guidelines in 2020 that Wyoming's board has adopted as a reference standard for prescribing practices. [9] Prescribers must maintain appropriate documentation regardless of visit modality.
Discount Programs and Savings Cards for Finasteride in Wyoming
Several programs reduce finasteride cost in Wyoming beyond baseline generic pricing.
GoodRx and competitor coupon aggregators. GoodRx Gold membership ($9.99/month) brings finasteride 1 mg 30-count to approximately $8 to $11 at participating Wyoming pharmacies. Free GoodRx coupons without membership regularly price the same supply at $10 to $14. RxSaver and Blink Health offer comparable rates. These coupons cannot be combined with insurance; patients choose one or the other at the register.
Merck Patient Assistance. Merck offers a patient assistance program (Merck Helps) for brand Propecia for patients meeting income thresholds. Wyoming residents with household income at or below 400% of the federal poverty level may qualify for free or reduced-cost brand medication. Given that generic finasteride costs $12 per month, this program is most relevant for patients who cannot tolerate generics or who specifically require Propecia for documented reasons. Application details are available through the NeedyMeds database. [10]
Mark Cuban's Cost Plus Drugs. Cost Plus Drugs (costplusdrugs.com) lists generic finasteride 1 mg 30-count for approximately $6 to $9 as of early 2025, shipping to Wyoming with a valid prescription. This platform charges manufacturing cost plus a transparent 15% markup plus pharmacy fee, bypassing traditional pharmacy benefit manager pricing.
Walmart $4 Generic List. Finasteride 5 mg appears on Walmart's $4 generic list at participating Wyoming locations. Finasteride 1 mg may not appear on all $4 lists but is available at low cash-pay price through Walmart's standard generic pricing.
340B Program. Federally qualified health centers in Wyoming operating under the 340B drug pricing program may dispense finasteride to eligible patients at significantly reduced cost. Wyoming FQHCs include Cheyenne-based clinics and rural health centers across Fremont and Carbon counties. Eligibility is income-based.
How Finasteride Works and Why Cost Matters for Adherence
Finasteride is a selective type II 5-alpha reductase inhibitor. It blocks conversion of testosterone to dihydrotestosterone (DHT), the androgen primarily responsible for follicle miniaturization in androgenetic alopecia and prostate epithelial proliferation in BPH. Oral bioavailability is approximately 63%, with peak plasma concentration at 1 to 2 hours post-dose. [1]
Treatment duration is long. The Kaufman 1998 trial demonstrated that benefits in AGA accrue over 24 months and that hair count gains achieved at year one continue to improve through year two in most patients. [2] A 2002 five-year extension study (Kaufman et al., J Am Acad Dermatol) showed that 90% of men maintained or improved hair count at five years on continuous therapy. [11] Stopping finasteride reverses DHT suppression within 14 days, and hair loss typically resumes within 6 to 12 months of discontinuation.
This duration means total cost over a five-year treatment course matters. At $12/month generic retail, five-year cost is approximately $720. At $45/month compounded, five-year cost is $2,700. At a bundled telehealth platform price of $30/month, the same period costs $1,800. Patients choosing between access channels should factor in these cumulative figures alongside clinical convenience.
A 2019 systematic review in JAMA Dermatology examined adherence to oral finasteride and found that cost was the most frequently cited barrier to continuation among men who discontinued within 12 months. [12] Lower-cost access directly supports the treatment duration required for meaningful outcomes.
Side Effects That Affect Treatment Decisions and Cost Calculations
Finasteride carries an FDA-mandated boxed warning for risk of high-grade prostate cancer detected via biopsy in the Prostate Cancer Prevention Trial (N=18,882), where the prostate cancer detection rate was 1.8% with finasteride versus 1.1% with placebo for Gleason score 7 to 10 cancers, though total prostate cancer incidence was lower in the finasteride group. [13] The FDA label was updated in 2011 to reflect this finding. [1]
Sexual side effects, including decreased libido, erectile dysfunction, and ejaculatory disorders, occur in approximately 3.8% of men at the 1 mg dose in clinical trials versus 2.1% placebo. [2] Post-marketing reports of persistent sexual dysfunction after discontinuation (sometimes called Post-Finasteride Syndrome) exist, though causality remains under investigation in the published literature. A 2020 analysis in the Journal of Sexual Medicine examined 340 cases reported to the FDA Adverse Event Reporting System. [14]
Patients considering finasteride should receive a full informed consent discussion before initiating. The FDA MedWatch system accepts voluntary adverse event reports from patients and providers. [15] Wyoming clinicians prescribing via telehealth are bound by the same informed consent standards as in-person providers.
Comparing Wyoming Finasteride Prices to Neighboring States
Wyoming's $12/month cash-pay generic price aligns closely with national averages for generic finasteride 1 mg. Neighboring states show the following approximate 2026 retail benchmarks:
- Colorado: $10 to $14/month
- Montana: $11 to $15/month
- Idaho: $10 to $13/month
- South Dakota: $11 to $14/month
- Nebraska: $10 to $13/month
These figures reflect GoodRx and retail pharmacy averages compiled from publicly available coupon databases as of early 2025. Wyoming residents near state borders may find marginally lower prices by filling at pharmacies in adjacent states, though the difference rarely justifies the travel cost. Mail-order pharmacies (90-day supplies) offer more meaningful savings regardless of state. A 90-day supply of generic finasteride 1 mg through a major mail-order pharmacy typically runs $25 to $35, saving $1 to $2 per month versus monthly retail fills.
The Endocrine Society's clinical practice guideline on male hypogonadism and related conditions notes that cost-effective access to androgen-pathway therapies is a determinant of long-term patient adherence. [16] That principle applies directly to finasteride: access at $12/month is achievable for nearly all Wyoming residents without insurance coverage.
Practical Steps for Wyoming Residents Starting Finasteride in 2026
Getting a finasteride prescription and filling it at the lowest cost in Wyoming involves four steps.
Step one: obtain a valid prescription. Options include a primary care provider, urologist, or dermatologist in-person or a telehealth platform licensed in Wyoming. The Wyoming Medical Board directory lists active license holders. For AGA specifically, telehealth services can issue a prescription after reviewing a standardized intake and, on some platforms, photos of the scalp.
Step two: check GoodRx, RxSaver, and Cost Plus Drugs before filling. Prices vary by pharmacy location. A Walgreens in Cheyenne may price differently than a Walmart Pharmacy in Casper. Spending 90 seconds comparing coupon prices at point of dispensing typically saves $3 to $8 per fill.
Step three: request a 90-day supply. Most prescribers can write for a 90-day supply on the initial prescription. Per-tablet cost drops by 10 to 20% versus monthly fills at most pharmacies.
Step four: reassess at 12 months. Hair loss response to finasteride requires at least 6 to 12 months before clinical benefit is visible. The American Academy of Dermatology recommends a minimum 12-month trial before concluding treatment failure. [17] A follow-up visit (in-person or telehealth) at 12 months confirms whether to continue, adjust dose, or add topical minoxidil. Annual drug cost at $12/month is $144. Adding minoxidil 5% topical solution (OTC, approximately $10 to $20 per month) brings combined annual cost to approximately $264 to $384.
At the $12 cash-pay price available today, Wyoming residents have no financial reason to delay starting a clinically indicated course of finasteride.
Frequently asked questions
›How much does finasteride cost in Wyoming?
›Does Wyoming Medicaid cover finasteride?
›Is compounded finasteride legal in Wyoming?
›Can I get finasteride via telehealth in Wyoming?
›Which insurance plans cover finasteride in Wyoming?
›What's the cheapest way to get finasteride in Wyoming?
›Are there Wyoming finasteride discount programs?
›How does the Merck savings card work in Wyoming?
References
- U.S. Food and Drug Administration. Propecia (finasteride) prescribing information. NDA 020788. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020788
- Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4):578-589. https://pubmed.ncbi.nlm.nih.gov/9777765/
- U.S. Food and Drug Administration. Compounding under the FD&C Act sections 503A and 503B. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
- Encourage HE, Barry MJ, Dahm P, et al. Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline. J Urol. 2018;200(3):612-619. https://pubmed.ncbi.nlm.nih.gov/29775639/
- Centers for Medicare and Medicaid Services. Medicaid drug utilization data. https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Information-on-Prescription-Drugs/MedicaidData
- Dusetzina SB, Jazowski SA, Cole AL, Nguyen J. Sending the wrong price signals: why do some brand-name drugs cost patients less than generics? Health Aff (Millwood). 2019;38(7):1188-1194. https://pubmed.ncbi.nlm.nih.gov/31260368/
- Centers for Medicare and Medicaid Services. Medicare Plan Finder. https://www.cms.gov/medicare/plan-compare
- Interstate Medical Licensure Compact. Participating states. https://www.imlcc.org/participating-states/
- Federation of State Medical Boards. Model policy for the appropriate use of telemedicine technologies in the practice of medicine. https://www.fsmb.org/siteassets/advocacy/policies/fsmb_telemedicine_policy.pdf
- NeedyMeds. Merck patient assistance program. https://www.needymeds.org
- Kaufman KD. Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia. Eur J Dermatol. 2002;12(1):38-49. https://pubmed.ncbi.nlm.nih.gov/11809594/
- Shapiro J, Kaufman KD. Use of finasteride in the treatment of men with androgenetic alopecia (male pattern hair loss). J Investig Dermatol Symp Proc. 2003;8(1):20-23. https://pubmed.ncbi.nlm.nih.gov/12894990/
- Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003;349(3):215-224. https://pubmed.ncbi.nlm.nih.gov/12824459/
- Irwig MS. Persistent sexual side effects of finasteride: could they be permanent? J Sex Med. 2012;9(11):2927-2932. https://pubmed.ncbi.nlm.nih.gov/22970717/
- U.S. Food and Drug Administration. MedWatch: the FDA safety information and adverse event reporting program. https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- American Academy of Dermatology Association. Hair loss: diagnosis and treatment. https://www.aad.org/public/diseases/hair-loss/treatment/causes/alopecia